John King
Member since: Dec 12, 2025
Published articles: 6
Clinical trials today are far more complex than ever before. With massive amounts of patient data, lab reports, imaging results, and electronic outcomes being collected, research teams need a smarter...
Colorectal cancer (CRC) remains one of the leading causes of cancer-related morbidity and mortality worldwide, despite substantial advances in screening, surgical techniques, and systemic therapies...
Cancer clinical trials remain the cornerstone of oncologic drug development and evidence-based care. Yet alongside their undeniable contributions, a growing body of literature and regulatory...
Clinical trials remain the cornerstone of therapeutic progress in oncology. Breakthroughs in treatments for prostate cancer — from androgen receptor–targeted therapies to radioligand therapy — have...
Re-examining the Cancer Clinical Trial Framework: Systemic Challenges and Practical LimitationsClinical trials remain the cornerstone of therapeutic advancement in oncology. Without them, the...
Re-examining the Cancer Clinical Trial Framework: Systemic Challenges and Practical LimitationClinical trials remain the cornerstone of therapeutic advancement in oncology. Without them, the evolution...